Catalyst Wire Dossier Catalyst Wire Dossier

DMB-3111

DMB-3111 · Meiji Seika Pharma Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DMB-3111, covering 2015-02-10 to 2015-02-10. Get the full timeline:

Most recent: Clinical Trial Update: Bioequivalence Study Evaluating the Pharmacokinetics of DMB-3111 and Trastuzumab in Healthy Japanese Male Adults [Phase 1]

See pricing